Melanocortin receptor-specific compounds
US7964601B2 · kind B2 · utility
4Cited by
91References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 2008 |
| Grant date | Jun 21, 2011 |
| Priority date | — |
| Expiry date | Apr 10, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A melanocortin receptor-specific compound of the general formula of structure I:where X, R1, R2a, R2b, R3, R4a, R4b, R5a and R5b are as defined in the specification, which compound binds with high affinity to one or more melanocortin receptors and is optionally an agonist, an antagonist, an inverse agonist or an antagonist of an inverse agonist, and may be employed for treatment of one or melanocortin receptor-associated conditions or disorders, and methods for the use of the compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.